Boston, February 16, 2017 – The State Key Laboratory of Natural and Biomimetic Drugs at Peking University has licensed RegMol and Scilligence Inventory systems. This state-of-the-art informatics platform will centralize data and sample management, and facilitate collaborations at the State Key Laboratory.
Scilligence is a leading innovator of web-based cheminformatics and bioinformatics solutions designed for any device, browser, and platform. Scilligence’s tools enhance the knowledge sharing and productivity of researchers in discovery and development of small molecule and biologic therapeutics.
The State Key Laboratory of Natural and Biomimetic Drugs at Peking University
The State Key Laboratory of Natural and Biomimetic Drugs, established in 1985, consists of an award-winning staff and multiple research groups making strides in a wide-range of disciplines including synthetic medicinal chemistry, natural drug, pharmacology, pharmaceutics, and more. The laboratory focuses on both fundamental and applied research in natural and biomimetic drugs to help tackle major diseases, such as tumors, cardio-cerebrovascular diseases, mental illnesses and viral infections. The laboratory accomplished the improbable in the fields of nucleic acid chemistry, carbohydrate chemistry, glycobiology, bioinorganic chemistry, natural product, and Chinese herbal medicine and has passed four assessments organized by the Ministry of Science and Technology with favorable results.